Literature DB >> 25059106

Intracystic interferon therapy in childhood craniopharyngioma: who, when and how?

Simon Bailey1, Jeannette Parkes.   

Abstract

A 13-year-old male presents with fluctuating visual disturbance and headaches. Imaging reveals a significant predominantly cystic suprasellar tumour, typical of a craniopharyngioma. The patient has growth hormone deficiency but the rest of the hypothalamic/pituitary axis is intact. What are the options for therapy in 2014? Specifically, is there a role for local treatment with interferon injected into the cyst cavity? The aim of management in children with craniopharyngiomas is to reduce the impact of the tumour as much as possible, while minimising the morbidity associated with treatment. There are a number of therapeutic options available: surgery, radiotherapy and the insertion of therapeutic agents directly into the tumour cyst. The role of intracystic therapy in the form of interferon is discussed; including when to use this therapeutic option and practical details of its use.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25059106     DOI: 10.1111/cen.12568

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Interferon or late effect of radiotherapy?

Authors:  Ulrika Sandvik; Pernilla Grillner; Stefan Holm; Bengt Gustavsson
Journal:  Childs Nerv Syst       Date:  2016-01-13       Impact factor: 1.475

2.  Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN.

Authors:  John-Paul Kilday; Massimo Caldarelli; Luca Massimi; Robert Hsin-Hung Chen; Yi Yen Lee; Muh-Lii Liang; Jeanette Parkes; Thuran Naiker; Marie-Lise van Veelen; Erna Michiels; Conor Mallucci; Benedetta Pettorini; Lisethe Meijer; Christian Dorfer; Thomas Czech; Manuel Diezi; Antoinette Y N Schouten-van Meeteren; Stefan Holm; Bengt Gustavsson; Martin Benesch; Hermann L Müller; Anika Hoffmann; Stefan Rutkowski; Joerg Flitsch; Gabriele Escherich; Michael Grotzer; Helen A Spoudeas; Kristian Azquikina; Michael Capra; Rolando Jiménez-Guerra; Patrick MacDonald; Donna L Johnston; Rina Dvir; Shlomi Constantini; Meng-Fai Kuo; Shih-Hung Yang; Ute Bartels
Journal:  Neuro Oncol       Date:  2017-10-01       Impact factor: 12.300

Review 3.  Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.

Authors:  Hermann L Müller
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

Review 4.  The Role of Surgical Approaches in the Multi-Modal Management of Adult Craniopharyngiomas.

Authors:  Christopher S Hong; Sacit Bulent Omay
Journal:  Curr Oncol       Date:  2022-02-24       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.